4th Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Opposition to medical device industry tax in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act." Opposition to cosmetic surgery tax in H.R. 3590, "Patient Protection and Affordable Care Act."

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (111th), H.R. 3962 (111th)

Health Issues HCR

Follow-on biologics provisions in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act." Support for H.R. 1548, "Pathway for Biosimilars Act." FDA approval and enforcement issues. Issues related to obesity assessment and treatment.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th), H.R. 3962 (111th), H.R. 3590 (111th)

Medicare/Medicaid MMM

Opposition to Medicare rebates in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act." Coding and payment for follow-on biologics in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act."

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3962 (111th), H.R. 3590 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.